04282nam 2200745 a 450 991082916890332120240516064703.09786613693754978128078336412807833629780470720011047072001897804707176840470717688(CKB)1000000000688064(EBL)703843(OCoLC)797918286(SSID)ssj0000715066(PQKBManifestationID)11454815(PQKBTitleCode)TC0000715066(PQKBWorkID)10700943(PQKB)10034091(MiAaPQ)EBC703843(Au-PeEL)EBL703843(CaPaEBR)ebr10575485(CaONFJC)MIL369375(Perlego)2769820(EXLCZ)99100000000068806420740422d1973 uy 0engur|n|---|||||txtccrImmunopotentiation1st ed.Amsterdam Elsevier19731 online resource (368 pages)Ciba Foundation symposium (new series) ;18"Symposium on Immunopotentiation, held at the Ciba Foundation, London, 18th-19th January 1973"--Participants page.9780470663110 0470663111 9789021940199 9021940191 Includes bibliographical references and indexes.Immunopotentiation; Contents; Introduction; The cellular targets for the action of adjuvants : T-adjuvants and B-adjuvants; Discussion; The relation of lymphocyte trapping to the mode of action of adjuvants; Discussion; Immunopotentiation by mycobacteria in complete Freund-type adjuvant as the failure of normal immunological homeostasis; Discussion; Effects of adjuvants on different cell types and their interactions in immune responses; Discussion; Cellular mechanisms underlying the adjuvant activity of Corynebacterium parvurn: interactions of activated macrophages with T and B lymphocytesDiscussionChemotaxis of macrophages : the role of a macrophage-specific cytotaxin from anaerobic corynebacteria and its relation to immunopotentiation in vivo; Discussion; The allogeneic effect on the immune system and its potential applications to tumour immunity; Discussion; Mitogens as probes for immunocyte activ- ation : specific and non-specific paralysis of B cell mitogenesis; Discussion; General Discussion I The T cell-deprived mouse; The use of viruses as immunological potentiators; DiscussionCorynebacterium parvum, a potent immunostimu-lant in experimental infections and in malignanciesDiscussion; Orchidectomy as a method of immunopotentiation in mice; Discussion; The nature of immunopotentiation by the anti-tumour polysaccharide lentinan and the significance of biogenic amines in its action; Discussion; The effect of Corynebacterium parvum and other reticuloendothelial stimulants on transplanted tumours in mice; Discussion; Attempt at using systemic immunity adjuvants in experimental and human cancer therapy; DiscussionGeneral Discussion II Restoration of immune capability in cancer patientsSites of action of adjuvants; Conclusion; Index of contributors; Subject indexThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. Ciba Foundation symposium ;new ser. 18.Immunological adjuvantsCongressesTumorsImmunological aspectsCongressesImmunological adjuvantsTumorsImmunological aspects574.2/9Ciba Foundation.Symposium on ImmunopotentiationMiAaPQMiAaPQMiAaPQBOOK9910829168903321Immunopotentiation2190300UNINA